A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of uncertain source.
Several experts stated the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking fines, legal action or prison.
Service Reaction and Material Elimination
Based on TikTok, the platform has taken down problematic content and banned associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing compliance measures.
Online Marketplace Operations
Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at residence.
Within moments of joining one community, a seller shared WhatsApp details, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, health issues or previous experience.
Product Details and Pricing
Within these communities, messages display black plastic packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When asked how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious health risks”.
